Olio Labs
Olio Labs is a remote healthcare company specializing in AI-driven drug discovery and delivery, focusing on developing combination therapeutics for obesity with reduced side effects.
Company Overview
Olio Labs is a healthcare company that operates fully remotely. Founded in 2023, Olio Labs specializes in the drug discovery and delivery sub-industry. The company is part of Y Combinator's Summer 2023 batch. Their primary focus is on developing combination therapeutics targeting obesity with fewer side effects than existing treatments like Ozempic.
Industry and Specialization
Olio Labs operates within the healthcare industry, specifically focusing on drug discovery and delivery. The company's innovation includes using artificial intelligence to develop combination therapeutics designed to treat obesity. Their approach aims to find optimal therapeutic combinations with reduced side effects.
Technological Approach
Olio Labs leverages custom machine learning models built from real-world expertise and cutting-edge AI. Their technology is designed to search through trillions of combinations to identify the most effective therapeutic solutions. This advanced AI-driven approach distinguishes Olio Labs in the drug discovery and delivery sector.
Company Launch and Y Combinator Involvement
Launched in 2023, Olio Labs is part of Y Combinator's Summer 2023 (S23) batch. This involvement has provided the company with significant backing and resources, facilitating its growth and development in the competitive healthcare landscape.
Contact Information
Olio Labs welcomes inquiries and can be contacted via email at hello@oliolabs.co. The company operates fully remotely, making it accessible from any location around the world.